🟢 Edesa Biotech is trading 5.4% up today with no new company-specific announcement identified

Edesa Biotech is trading 5.40% up at $2.93 on October 20, 2026, with no new company-specific announcement identified for the move.

• The latest located company catalyst was the October 15 FDA clearance to expand its Phase 2 EB06 vitiligo study into the United States; that news is several days old.
• Biotech was up 2.09%, a possible sector backdrop that does not establish the cause of Edesa Biotech’s move.
• Shares gained 8.17% on October 19; trading volume or activity-level data was not provided.